- Pharmaceutical companies
- Viatris
Viatris
Phone: +17245141800
Type | Public |
---|---|
Traded as |
|
ISIN | US92556V1061 |
Industry |
|
Predecessors |
|
Founded | November 16, 2020 (2020-11-16) |
Headquarters | Canonsburg, Pennsylvania, U.S. |
Area served | Worldwide |
Key people |
|
Products |
|
Revenue | US$17.89 billion (2021) |
Net income | US$−1.27 billion (2021) |
Total assets | US$54.84 billion (2021) |
Total equity | US$20.49 billion (2021) |
Number of employees | c. 37,000 (December 2021) |
Website | viatris.com |
At Viatris, we have one of the strongest global commercial infrastructures in the industry, with a balanced reach across North America, Europe, the Asia Pacific region and emerging markets. Our high quality global manufacturing, scientific excellence and vast supply chain network mean we are uniquely positioned to improve access to medicine for patients worldwide.
For detailed contact information visit location pages below.
Viatris's locations around the world
Europe
North America
South America
Oceania
Clinical Trials sponsored by Viatris
-
Viatris KoreaRekrytointiPerifeerinen neuropaattinen kipuKorean tasavalta
-
Viatris Specialty LLCValmis
-
Viatris Specialty LLCValmisVäärinkäyttömahdollisuusYhdysvallat
-
Viatris Specialty LLCValmisVäärinkäyttömahdollisuusYhdysvallat
-
Viatris Pharmaceuticals Japan IncValmis
-
Viatris Inc.Ei vielä rekrytointiaBioekvivalenssitutkimusThaimaa
-
Viatris Inc.Ei vielä rekrytointiaKrooninen sydämen vajaatoiminta
-
MEDA PHARMA SPA, a Viatris companyEi vielä rekrytointiaLievästä kohtalaiseen atooppiseen ihottumaan
-
COPD FoundationViatris Inc.Rekrytointi